SEC Form 4 · accession 0001053369-17-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — CEO & President · Director · 10% Owner
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2017 | A | 2,216,992 | $0.2255 | A | 24,143,785 | D | |
| Common Stock | holding | — | — | — | 2,700,000 | I | by IRA | |
| Common StockF1 | holding | — | — | — | 142,971,097 | I | see footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.